Artal International Management S.A.

CIK 1522131 · last filed 2024-03-13

Artal International Management S.A. is a corporate insider who has filed 4 SEC Form 4 insider transactions across 4 companies since 2012. The most recent filing shows the insider was granted $1.25B of LXRX on Mar 13, 2024. Across all open-market trades the lifetime net is −$6.95B, making them a net seller over the disclosed history. Current disclosed insider exposure totals $7.52B across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$7.52B

Companies

4

Total Filings

4

Lifetime Open-Market Net

-$6.95B

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
LXRX	Director	1,150,922	$2.22	$2.56M	$0	1	2024-03-13
WW	10%+ Owner	0	$17.55	$0	-$741.66M	1	2023-05-11
CRESCENT BIOPHARMA, INC. (GLYC) Delisted	10%+ Owner	7,573,798	$15.70	$118.91M	$24.22M	1	2023-02-17
WTW	10%+ Owner	28,749,089	$261.50	$7.52B	-$6.23B	1	2012-04-11

Recent Filings

4 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2024-03-13	LXRX	Grant (A)	+11,509,220	$1.25B	EDGAR
2023-05-11	WW	Sell (S)	−103,728,100	-$741.66M	EDGAR
2023-02-17	CRESCENT BIOPHARMA, INC. (GLYC) Delisted	Buy (P)	+12,122,128	$24.22M	EDGAR
2012-04-11	WTW	Sell (S)	−75,990,432	-$6.23B	EDGAR

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.